Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years.

T Arrigo, G Crisafulli, A Salamone, D Cucinotta, F De Luca
{"title":"Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years.","authors":"T Arrigo,&nbsp;G Crisafulli,&nbsp;A Salamone,&nbsp;D Cucinotta,&nbsp;F De Luca","doi":"10.1515/jpem.1994.7.3.269","DOIUrl":null,"url":null,"abstract":"<p><p>This case report concerns a prepubertal patient (height 148.7 cm) with congenital anterior panhypopituitarism diagnosed at the chronological age of 25.2 years (bone age 12.5). In spite of his advanced age on initiation of hormonal replacement therapy this patient achieved an adult height (172.8 cm), exceeding those of his father and brothers, because of his markedly delayed bone age. This satisfactory height outcome confirms that final height in hypopituitarism depends on both height at onset of puberty and height with respect to bone age but not chronological age at initiation of growth hormone treatment.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"269-72"},"PeriodicalIF":0.0000,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.269","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of pediatric endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/jpem.1994.7.3.269","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

This case report concerns a prepubertal patient (height 148.7 cm) with congenital anterior panhypopituitarism diagnosed at the chronological age of 25.2 years (bone age 12.5). In spite of his advanced age on initiation of hormonal replacement therapy this patient achieved an adult height (172.8 cm), exceeding those of his father and brothers, because of his markedly delayed bone age. This satisfactory height outcome confirms that final height in hypopituitarism depends on both height at onset of puberty and height with respect to bone age but not chronological age at initiation of growth hormone treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
25岁以后诊断为先天性垂体功能减退症的成人身高超过目标身高1例。
本病例报告涉及一名青春期前患者(身高148.7 cm),在实足年龄25.2岁(骨年龄12.5岁)时被诊断为先天性前垂体功能减退症。尽管在开始激素替代治疗时,患者已年事已高,但由于骨龄明显延迟,患者达到了成人身高(172.8 cm),超过了他的父亲和兄弟。这一令人满意的身高结果证实,垂体功能减退症的最终身高取决于青春期开始时的身高和与骨龄相关的身高,而不是生长激素治疗开始时的实足年龄。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Priming with GHRH (1-29) NH2: an aid in differential diagnosis between hypothalamic and pituitary deficiencies. The new highly sensitive adrenocorticotropin assay improves detection of patients with partial adrenocorticotropin deficiency in a short-term metyrapone test. The role of TRH-stimulated prolactin responses in distinguishing gonadotropin deficiency from constitutional delayed puberty. A randomized trial of a somatostatin analog for preserving beta cell function in children with insulin dependent diabetes mellitus. Both glucagon excess and insulin deficiency characterize maturity-onset diabetes mellitus of youth (MODY).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1